Skip to main content
    V

    vTv Therapeutics Inc (VTVT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $17.29
    -0.40 (-2.26%)

    Market Cap: $78.99M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    vTv Therapeutics Inc (VTVT) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    vTv Therapeutics (VTVT) has a latest price of $17.29 on Nov 17, 2026, 60.7% below its 52-week high of $44.00. Its price fell 43.9% over the past 12 months. The month-end price fell 88.3% over the 10 years through Oct 2026, a compound annual decline of 19.3%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $310.40 in Jan 2018 and its lowest $8.41 in Jan 2024, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart VTVT with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VTVT.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 47.4%, and over 6 months it fell 52.6%. The month-end price rose 50.9% over the 3 years through Oct 2026, a compound annual rate of 14.7%.

    PeriodChange
    1 month-35.8%
    3 months-47.4%
    6 months-52.6%
    12 months-43.9%
    12 months, with dividends-43.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+50.9%+14.7%
    5 years-56.0%-15.1%
    10 years-88.3%-19.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 189.6%, and its weakest was 2023, when it fell 56.6%.

    YearCloseChange
    2026 through Oct 2026$25.17-37.1%
    2025$39.99+189.6%
    2024$13.81+20.1%
    2023$11.50-56.6%
    2022$26.51-33.4%
    2021$39.80-46.5%
    2020$74.40+9.4%
    2019$68.00-35.8%
    2018$106.00-55.9%
    2017$240.40+24.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 36.9% below its 50-day average of $27.42 and 47.1% below its 200-day average of $32.70.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$17.29
    52-week high$44.00-60.7%
    52-week low$17.28+0.1%
    50-day average$27.42-36.9%
    200-day average$32.70-47.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 59.5%.

    MeasureValue
    1-year beta1.41
    Largest fall, 1 year-59.5%
    Largest fall, 3 years-59.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About VTVT

    What is VTVT's 1-year price change?

    vTv Therapeutics's price fell 43.9% over the past 12 months. With dividends included, the 12-month total return was -43.9%.

    What is VTVT's 5-year price change?

    vTv Therapeutics's month-end price fell 56.0% over the 5 years through Oct 2026, a compound annual decline of 15.1%. These figures leave out dividends.

    What is VTVT's 52-week high and low?

    vTv Therapeutics's 52-week high is $44.00 and its 52-week low is $17.28. Its latest price of $17.29 on Nov 17, 2026 is 60.7% below the high.

    What is VTVT's beta?

    vTv Therapeutics's 1-year beta against the S&P 500 is 1.41, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 59.5%.

    Is the VTVT chart free?

    Yes. Advanced Charting for VTVT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.